Health & Fitness
Diabetes Self-Management

Diabetes Self-Management March/April 2019

Diabetes Self-Management offers up-to-date, practical “how-to” information on nutrition, exercise, new drugs, medical advances, self-help, and the many other topics people need to know about to stay healthy.

United States
Madavor Media, LLC
Read More
6 Issues

in this issue

1 min.
metformin everything you wanted to know

Metformin is the most widely used diabetes medicine in the world. Find out about early setbacks in metformin’s development; what finally established the medicine as the first-line diabetes treatment; good, bad and neutral side effects of the drug; and more. Readers have responded to our recent interview with ESPN’s Adam Schefter on raising diabetes awareness and his personal connection to Type 1. Here’s a sampling: Thank you, Adam. At 25 years old I’ve been Type 1 for 23 of them… Keep up the good work, let’s continue to raise awareness and fight for the cure! –Jared I didn’t know your connection to #T1D and hope to see more prominent voices help build awareness & advocacy. My son was diagnosed 1⅔1/14 at age 8. #T1DLooksLikeMe –Rebecca S. VIDEO Blood Glucose Monitoring Learn more about recommended blood glucose…

2 min.
spring forward

As March rolls in, the signs of spring are starting to sprout. Days are longer and brighter, with Mother Nature anxiously waiting to turn the seasonal page. But springtime is far more than blooming flowers and budding leaves. It’s a time of year that spurs a need to spring clean, take on new projects and adventures, and recommit to your personal goals. This issue of Diabetes Self-Management is chock-full of inspiration. If part of your project list is to enter (or re-enter) the dating scene, long time contributor Nicola Davies, PhD, tackles first-date jitters and online dating, and offers strategies to help people with diabetes successfully navigate the art of dating. Maybe your goal is to find new technologies to help you better manage your diabetes. In the Technologies Watch List 2019…

1 min.
treating diabetes a new strategy

Researchers in France have announced they have discovered new information about the workings of an important enzyme in the body—information that might lead to the development of new drugs for Type 2 diabetes. The enzyme is called hormone-sensitive lipase (HSL). It converts fats into fatty acids and then releases them into the bloodstream. In people who are overweight, these fatty acids promote insulin resistance, a condition that is often a precursor of diabetes. The scientists were from Inserm, a public research organization in France devoted to the study of human health, and were led by Dominique Langin, PhD. They had previously discovered that decreasing the production of HSL leads to better insulin response. In this latest research, they explored how this reduction in HSL actually caused the beneficial effect. To their surprise,…

1 min.
can metformin prevent cancer?

A few reports have suggested that people who take metformin, one of the most widely prescribed drugs for diabetes patients, have a lower risk of getting colorectal cancer. Later reviewers of these studies, however, have concluded that they were possibly flawed, which left the question open. To address that concern, researchers recently conducted a study of the relationship between metformin use and colorectal cancer and came away with some good news: long-term use of metformin is associated with a decreased risk for colorectal cancer in men with diabetes. As one of the authors described, “If our findings are confirmed, metformin may have a role in the chemoprevention of colorectal cancer.” The study involved people who participated in the Kaiser Permanente Northern California Diabetes Registry. The subjects were at least 40 years old,…

1 min.
arthritis drug might help diabetes

A medication used to treat rheumatoid arthritis (RA) might also be useful in lowering blood sugar levels in people with diabetes, according to a new report from researchers in China. The drug is leflunomide, which has been used to treat RA for nearly two decades. According to Xiulong Xo, PhD, of Yangzhou University, it “could potentially be useful for treating patients with both RA and diabetes.” Xo said his team of researchers studied how leflunomide “works at a molecular level” and discovered that it targets a protein that’s involved in desensitizing the insulin receptor. Because the insulin receptor instructs the cells to start absorbing sugar from the bloodstream, the researchers speculated that leflunomide could play a role in blood glucose management. To test their theory, they administered leflunomide to obese mice…

3 min.
 diabetes quiz

Questions How Much Do You Know about Diabetes and Bone and Joint Disorders? People who have Type 1 or Type 2 diabetes are at greater risk for hip injuries than people who don’t have diabetes, according to a 2007 study published in Osteoporosis International. For people managing diabetes, osteoporosis, a condition that causes bones to weaken and become brittle, often takes a back seat when it comes to other diabetes complications (e.g., blindness, kidney disease, heart disease, or even leg amputation). But diabetes plays a stronger role in bone and joint health and may cause bone brittleness. Take this quiz to see how much you know about the role diabetes plays in bone and joint disorders. 1. In addition to diabetic neuropathy, having diabetes increases your risk for which of the following bone/joint…